ATHX

Athersys Partner HEALIOS K.K. Announces Positive Topline Results of MultiStem for Acute Respiratory Distress Syndrome in the ONE-BRIDGE Study

New Publication Provides Further Clarity of MultiStem's Mechanism of Action on Modulating the Inflammatory Response in Critical Care Indications

Athersys: Stem Cell Opportunity For Risk-Tolerant Investors - Q1 2021 Update

Athersys, Inc. (ATHX) Management on Q1 2021 Results - Earnings Call Transcript

Athersys Reports That Healios Has Completed Enrollment in the ONE-BRIDGE Study of MultiStem® for Acute Respiratory Distress Syndrome in Japan

Athersys' (ATHX) Management on Q4 Full Year 2020 Results - Earnings Call Transcript